Laman UtamaDVA • NYSE
add
Davita Inc
Tutup sebelumnya
$144.57
Julat hari
$145.02 - $147.31
Julat tahun
$101.00 - $159.42
Permodalan pasaran
9.82B USD
Bilangan Purata
828.61K
Nisbah P/E
15.45
Hasil dividen
-
Pertukaran utama
NYSE
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 3.62B | 9.87% |
Perbelanjaan pengendalian | 659.06J | 11.97% |
Pendapatan bersih | 234.22J | -9.68% |
Margin untung bersih | 6.47 | -17.79% |
Pendapatan bagi setiap syer | 3.40 | 51.79% |
EBITDA | 737.91J | 12.69% |
Kadar cukai berkesan | 20.05% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 700.74J | -17.17% |
Jumlah aset | 17.48B | 1.13% |
Jumlah liabiliti | 16.32B | 7.42% |
Jumlah ekuiti | 1.16B | — |
Syer tertunggak | 66.80J | — |
Harga kepada buku | -15.22 | — |
Pulangan pada aset | 7.87% | — |
Pulangan pada modal | 9.79% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 234.22J | -9.68% |
Tunai daripada operasi | 540.73J | -1.26% |
Tunai daripada pelaburan | -163.13J | 34.22% |
Tunai daripada pembiayaan | -414.52J | 26.65% |
Perubahan bersih dalam tunai | -37.67J | 86.49% |
Aliran tunai bebas | 395.96J | 16.37% |
Perihal
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs.
The company is ranked 331st on the Fortune 500. Wikipedia
Diasaskan
1992
Ibu pejabat
Tapak web
Pekerja
78,000